Comparative Analysis of Transforaminal Interbody Fusion and Posterior Lumbar Interbody Fusion in Degenerative Spinal Disease

Authors

  • Fatima Akram Department of Neurosurgery, Rawalpindi Teaching Hospital Rawalpindi, Pakistan
  • Sundus Ali Department of Neurosurgery, Rawalpindi Teaching Hospital Rawalpindi, Pakistan
  • Basit Ali Khan Department of Neurosurgery, Rawalpindi Teaching Hospital Rawalpindi, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i5.2261

Keywords:

Degenerative lumbar disease, TLIF, PLIF, lumbar fusion, functional outcome

Abstract

Lumbar degenerative spinal diseases are a leading source of disability in all parts of the world and often necessitate surgical stabilization in cases where efforts to manage the same have failed. The most common ones include transforaminal lumbar interbody fusion (TLIF) and posterior lumbar interbody fusion (PLIF), but comparative evidence in low- and middle-income countries is limited.  Objective: To identify the comparable perioperative outcomes, functional recovery, radiographic fusion, and complication rates between TLIF and PLIF in patients undergoing surgery for degenerative lumbar spine disease.  Methods: It is a comparative observational study conducted at the Rawalpindi Teaching Hospital in Pakistan from 8 may 2024 to 8 April 2025. Sixty adult degenerative lumbar pathology patients who had to undergo a single- or two-level interbody fusion were selected and randomly assigned to TLIF (n = 30), or PLIF (n=30), either according to surgeon choice or shared decision. Demographics, comorbidities, operative variables and patient-reported outcomes, such as the Oswestry Disability Index (ODI) and Visual Analog Scale (VAS) for back and leg pain, were recorded. The patients were followed up for 12 months. The outcomes included the duration of surgery, blood loss, hospital stay, fusion rates, complications, and functional recovery. The comparative and multivariate analyses were performed at the p = 0.05 level.  Results: There were no significant differences in baseline demographic and clinical characteristics. TLIF was linked to much less intraoperative blood loss (median 300 mL vs. 420 mL, p< 0.001) and reduced hospital stay (median 3 vs. 4 days, p= 0.015). The 12-month radiographic fusion rate was even (93.3%TLIF vs. 90.0%PLIF;p = 0.64). The two groups showed similar, significant results in ODI and VAS scores at 12 months (p > 0.05). There were no significant differences in early and late complication rates. TLIF patients were able to walk independently earlier and go back to work sooner than PLIF patients. PLIF on adjusted analysis was not associated with functional or radiographic outcomes, but was nonetheless independently associated with greater blood loss and a longer hospital stay. Conclusion: TLIF and PLIF are both reasonable surgical procedures for degenerative lumbar spinal disease, and they give similar fusion rates, pain relief, and functional outcomes. TLIF is associated with benefits, including reduced blood loss, a short hospital stay and a quick postoperative recovery. These results endorse TLIF as a patient-focused and cost-effective tool, especially in healthcare settings with limited resources.

Downloads

Download data is not yet available.
49

References

1. Qin R., Wu T., Liu H., Zhou B., Zhou P., & Zhang X.. Minimally invasive versus traditional open transforaminal lumbar interbody fusion for the treatment of low-grade degenerative spondylolisthesis: a retrospective study. Scientific Reports 2020;10(1). DOI: https://doi.org/10.1038/s41598-020-78984-x

2. Potašová M., Filipp P., Rusnák R., Moraučíková E., Repová K., & Kutiš P.. Latest developments in minimally invasive spinal treatment in slovakia and its comparison with an open approach for the treatment of lumbar degenerative diseases. Journal of Clinical Medicine 2023;12(14):4755. DOI: https://doi.org/10.3390/jcm12144755

3. Caelers I., Kunder S., Rijkers K., Hemert W., Bie R., Evers S.et al.. Comparison of (partial) economic evaluations of transforaminal lumbar interbody fusion (tlif) versus posterior lumbar interbody fusion (plif) in adults with lumbar spondylolisthesis: a systematic review. Plos One 2021;16(2):e0245963. DOI: https://doi.org/10.1371/journal.pone.0245963

4. Wang T. and Ding W.. Risk factors for adjacent segment degeneration after posterior lumbar fusion surgery in treatment for degenerative lumbar disorders: a meta-analysis. Journal of Orthopaedic Surgery and Research 2020;15(1). DOI: https://doi.org/10.1186/s13018-020-02032-7

5. Tan Y., Tanaka M., Sonawane S., Uotani K., Oda Y., Fujiwara Y.et al.. Comparison of simultaneous single-position oblique lumbar interbody fusion and percutaneous pedicle screw fixation with posterior lumbar interbody fusion using o-arm navigated technique for lumbar degenerative diseases. Journal of Clinical Medicine 2021;10(21):4938. DOI: https://doi.org/10.3390/jcm10214938

6. Michael M., Stark M., & Woods B.. Effectiveness of intraoperative neuromonitoring in a patient undergoing a one-level transforaminal lumbar interbody fusion: a case report. Cureus 2023. DOI: https://doi.org/10.7759/cureus.35580

7. Tian A., Ma X., & Ma J.. Transforaminal and posterior lumbar interbody fusion for llumbar degenerative diseases, which one is better: a meta-analysis through a ggrade analysis of evidence. 2021. DOI: https://doi.org/10.21203/rs.3.rs-910433/v1

8. El-Ghandour N., Sawan M., Goel A., Abdelkhalek A., Abdelmotleb A., Ali T.et al.. A prospective randomized study of the safety and efficacy of transforaminal lumbar interbody fusion versus posterior lumbar interbody fusion in the treatment of lumbar spondylolisthesis: a cost utility from a lower-middle-income country perspective and review of literature. Open Access Macedonian Journal of Medical Sciences 2021;9(B):636-645.

9. KHATTAK S., Rehman S., Anwer M., Saeed K., & RAHIM I.. Comparison of transforaminal lumbar interbody fusion and posterior lumbar interbody fusion in the management of single-level lumbar spondylolisthesis. Biological and Clinical Sciences Research Journal 2023;2023(1):412.

10. Zabat M., Kim L., Varghese P., O’Connell B., Kim Y., & Fischer C.. The impact of social determinants of health on discharge disposition following one- and two-level posterior interbody fusion. Cureus 2024. DOI: https://doi.org/10.7759/cureus.52939

11. KATUCH V., Grega R., Knorovsky K., BANOCI J., Kaťuchová J., Sasala M.et al.. Comparison between posterior lumbar interbody fusion and transforaminal lumbar interbody fusion in the management of lumbar spondylolisthesis. Bratislava Medical Journal 2021;122(09):653-656. DOI: https://doi.org/10.4149/BLL_2021_105

12. KHATTAK S., Rehman S., Anwer M., Saeed K., & RAHIM I.. Comparison of transforaminal lumbar interbody fusion and posterior lumbar interbody fusion in the management of single-level lumbar spondylolisthesis. Biological and Clinical Sciences Research Journal 2023;2023(1):412. DOI: https://doi.org/10.54112/bcsrj.v2023i1.412

13. Yoo S., Kim K., Chin D., Kim K., Cho Y., & Park J.. Minimally invasive versus conventional lumbar interbody fusion at l5–s1: a retrospective comparative study. Journal of Minimally Invasive Spine Surgery and Technique 2022;7(1):37-45. DOI: https://doi.org/10.21182/jmisst.2022.00472

14. El-Ghandour N., Sawan M., Goel A., Abdelkhalek A., Abdelmotleb A., Ali T.et al.. A prospective randomized study of the safety and efficacy of transforaminal lumbar interbody fusion versus posterior lumbar interbody fusion in the treatment of lumbar spondylolisthesis: a cost utility from a lower-middle-income country perspective and review of literature. Open Access Macedonian Journal of Medical Sciences 2021;9(B):636-645. DOI: https://doi.org/10.3889/oamjms.2021.6569

15. Roh Y., Soh J., Lee J., Jang H., Choi S., & Shin B.. Lower incidence of asp requiring surgery with minimally invasive tlif than with open plif. Clinical Spine Surgery a Spine Publication 2024;38(6):E340-E348. DOI: https://doi.org/10.1097/BSD.0000000000001741

16. Modi H. and Shreshtha U.. Clinical and radiological outcome following mis-tlif and open-tlif between asian and african population- a comparative retrospective analysis in 104 patients. bbj 2022;3(1):14-19. DOI: https://doi.org/10.13107/bbj.2022.v03i01.034

17. Nguyen A., Ross E., Westra J., Huang N., Nguyen C., Raji M.et al.. Opioid utilization in geriatric patients after operation for degenerative spine disease. Journal of Neurosurgical Anesthesiology 2020;33(4):315-322. DOI: https://doi.org/10.1097/ANA.0000000000000682

18. Chen M., Cui J., Liu Y., Cai Z., Yang C., Liu H.et al.. Comparison of safety and efficacy of posterior lumbar interbody fusion (plif) and modified transforaminal lumbar interbody fusion (m-tlif) in the treatment of single-segment lumbar degenerative diseases. Journal of Orthopaedic Surgery and Research 2024;19(1). DOI: https://doi.org/10.1186/s13018-024-04531-3

19. Ohrt‐Nissen S., Carreon L., Andresen A., Andersen M., & Udby P.. Clinical and patient-reported outcomes after posterior versus transforaminal lumbar interbody fusion—a propensity score-matched cohort study on 422 patients with 2-year follow-up. Spine 2021;47(2):180-185. DOI: https://doi.org/10.1097/BRS.0000000000004215

20. Deng Z., Zou Q., Wang L., Wang L., Xiu P., Feng G.et al.. Comparison between three‐dimensional printed titanium and peek cages for cervical and lumbar interbody fusion: a prospective controlled trial. Orthopaedic Surgery 2023;15(11):2889-2900.``` DOI: https://doi.org/10.1111/os.13896

Downloads

Published

2025-05-31

How to Cite

1.
Akram F, Ali S, Khan BA. Comparative Analysis of Transforaminal Interbody Fusion and Posterior Lumbar Interbody Fusion in Degenerative Spinal Disease. Biol Clin Sci Res J [Internet]. 2025 May 31 [cited 2026 Jun. 29];6(5):445-9. Available from: https://bcsrj.com/ojs/index.php/bcsrj/article/view/2261

Issue

Section

Original Research Articles

Categories

Similar Articles

<< < 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 > >> 

You may also start an advanced similarity search for this article.